Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.25 USD | -1.63% | +7.44% | +66.94% |
04-01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
04-01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.94% | 388M | |
+2.93% | 108B | |
+0.73% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- SVB Securities Downgrades Solid Biosciences to Market Perform From Outperform, Adjusts Price Target to $1 From $12